Sign In
Buy ELV
$388.50
-2.77 (-0.708%)
At Close: Jun 18, 2026
Elevance Health: Q3 Figures Underscore Slow But Steady Recovery
03:29am, Friday, 24'th Oct 2025
Elevance Health reaffirmed its long-term goal of targeting at least 12% average annual growth in adjusted diluted EPS. ELV trades at a forward P/E of 11.5, below UNH's at 22, suggesting undervaluation
HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members
08:00am, Wednesday, 22'nd Oct 2025
MINNEAPOLIS--(BUSINESS WIRE)-- #HistoSonics--HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members.
Elevance: Checking Out The Q3 Report
07:12am, Wednesday, 22'nd Oct 2025
Elevance Health reported Q3 results, beating consensus earnings estimates. However, the beat was due to one-off items. Key focus areas include Medical Cost Ratio stabilization, 2026 premium rate re-fi
Elevance Health Q3 Earnings Beat Estimates on Strong MA Membership
03:06pm, Tuesday, 21'st Oct 2025
ELV beats EPS estimates by 21% in Q3 as strong Medicare Advantage membership gains and Carelon revenue growth offset Medicaid losses.
Elevance Health, Inc. (ELV) Q3 2025 Earnings Call Transcript
11:54am, Tuesday, 21'st Oct 2025
Elevance Health, Inc. (NYSE:ELV ) Q3 2025 Earnings Call October 21, 2025 8:30 AM EDT Company Participants Nathan Rich - Vice President of Investor Relations Gail Boudreaux - President, CEO & Director
Elevance Health (ELV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
10:30am, Tuesday, 21'st Oct 2025
The headline numbers for Elevance Health (ELV) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Stre
Elevance Health's Profits Eclipse $1.1 Billion Despite Rising Costs
08:55am, Tuesday, 21'st Oct 2025
Elevance Health Tuesday said third quarter net income rose to nearly $1.2 billion despite rising costs in its government subsidized health insurance plans.
Elevance Health (ELV) Tops Q3 Earnings and Revenue Estimates
08:11am, Tuesday, 21'st Oct 2025
Elevance Health (ELV) came out with quarterly earnings of $6.03 per share, beating the Zacks Consensus Estimate of $4.98 per share. This compares to earnings of $8.37 per share a year ago.
Elevance beats quarterly profit estimates as medical costs remained in check
06:07am, Tuesday, 21'st Oct 2025
Elevance Health on Tuesday beat Wall Street estimates for third-quarter profit as the health insurer managed to keep medical costs in check.
Elevance Health Reports Third Quarter 2025 Results
06:00am, Tuesday, 21'st Oct 2025
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported third quarter 2025 results. "Our third quarter results were in line with expectations and reflect disciplined execution across
Elevance Health Draws Fresh Capital Inflows, According to Recent Filing
04:59pm, Thursday, 16'th Oct 2025
DAVENPORT & Co LLC added 353,748 shares of Elevance Health (ELV -0.38%), an estimated $110.02 million trade based on the average price for the quarter, per an October 15, 2025, SEC filing.
Wall Street's Insights Into Key Metrics Ahead of Elevance Health (ELV) Q3 Earnings
10:16am, Thursday, 16'th Oct 2025
Besides Wall Street's top-and-bottom-line estimates for Elevance Health (ELV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during
Will Rising Costs Hurt Elevance's Q3 Earnings Despite Higher Premiums?
02:56pm, Wednesday, 15'th Oct 2025
ELV's third-quarter earnings may face pressure as rising costs and weaker Medicaid memberships offset premium gains.
Analysts Estimate Elevance Health (ELV) to Report a Decline in Earnings: What to Look Out for
11:01am, Tuesday, 14'th Oct 2025
Elevance Health (ELV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SAN DIEGO , Oct. 14, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that an update in the lawsuit that is currently pending for certain investors in Elevance Health, Inc. (NYSE: ELV
